Flumazenil given intravenously:

Questions 52

ATI RN

ATI RN Test Bank

Pharmacology of Drugs Acting on Cardiovascular System PDF Questions

Question 1 of 5

Flumazenil given intravenously:

Correct Answer: B

Rationale: Step 1: Flumazenil is a benzodiazepine receptor antagonist used to reverse benzodiazepine overdose. Step 2: Given intravenously, it acts rapidly to competitively inhibit the effects of benzodiazepines. Step 3: Flumazenil has a short half-life of about 1 hour, resulting in a rapid onset but short duration of action. Step 4: Therefore, choice B is correct as it accurately describes the pharmacokinetics of flumazenil. Summary: Choices A, C, and D are incorrect because flumazenil does not have an intermediate onset and duration of action of about 2 hours, an effect lasting 3-5 hours, or a duration of action longer than 6 hours.

Question 2 of 5

Ethyl alcohol is an agent decreasing appetite. It’s:

Correct Answer: B

Rationale: Rationale: 1. Ethyl alcohol is a substance known to stimulate appetite, not decrease it. 2. Alcohol consumption often leads to increased hunger and overeating. 3. Therefore, the correct answer is B: FALSE. Summary: A: Incorrect - Ethyl alcohol does not decrease appetite. C: Incorrect - Ethyl alcohol does not decrease appetite for all individuals. D: Incorrect - Ethyl alcohol does have an impact on appetite.

Question 3 of 5

Aminocapronic acid is a drug of choice for treatment of:

Correct Answer: B

Rationale: The correct answer is B: Bleeding from fibrinolytic therapy. Aminocaproic acid is an antifibrinolytic agent that works by inhibiting the breakdown of blood clots. It is commonly used to manage excessive bleeding caused by fibrinolytic therapy, such as in cases of severe bleeding post-surgery or trauma. This drug helps to maintain clot stability and prevent further bleeding. Incorrect choices: A: Acute myocardial infarction - Aminocaproic acid is not indicated for the treatment of acute myocardial infarction. C: Heart failure - Aminocaproic acid is not used in the treatment of heart failure. D: Multiple pulmonary emboli - Aminocaproic acid is not typically used to treat multiple pulmonary emboli.

Question 4 of 5

All of the following calcium channel blockers are useful in the treatment of cardiac arrhythmias EXCEPT:

Correct Answer: D

Rationale: Rationale: Nifedipine is a dihydropyridine calcium channel blocker primarily used for hypertension and angina, not for cardiac arrhythmias. Bepridil, Diltiazem, and Verapamil are non-dihydropyridine calcium channel blockers that are effective in treating cardiac arrhythmias by slowing down the heart rate and controlling abnormal heart rhythms. Nifedipine does not possess significant antiarrhythmic properties compared to the other options, making it the incorrect choice for the treatment of cardiac arrhythmias.

Question 5 of 5

An endogenous vasoconstrictor that can stimulate aldosterone release from suprarenal glands:

Correct Answer: C

Rationale: The correct answer is C: Angiotensin II. Angiotensin II is an endogenous vasoconstrictor that can stimulate aldosterone release from the suprarenal glands. It is formed from the conversion of Angiotensin I by Angiotensin-converting enzyme (ACE). Angiotensinogen (choice A) is the precursor protein that is converted to Angiotensin I. Angiotensin-converting enzyme (choice D) is responsible for converting Angiotensin I to Angiotensin II, not for directly stimulating aldosterone release.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions